Mirum Pharmaceuticals Other Long Term Liabilities (Quarterly) Insights

Mirum Pharmaceuticals, Inc. (MIRM)

90.44 +0.94 (+1.05%) USD | NASDAQ | Jan 13, 16:00

90.44 0.00 (0.00%) After-Hours: 20:00

View Other Long Term Liabilities (Quarterly) for MIRM.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Long Term Liabilities (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Long Term Liabilities (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Long Term Liabilities (Quarterly) Benchmarks

Start Trial

Pfizer Inc.	Upgrade
XOMA Royalty Corp.	Upgrade
Arcutis Biotherapeutics, Inc.	Upgrade
Recursion Pharmaceuticals, Inc.	Upgrade
Insmed, Inc.	Upgrade